The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments
ConclusionThe survey responses highlight the activity of sirolimus for EHE and the importance of securing a label extension for the drug delivering equitable access to this treatment for patients.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Australia Health | Canada Health | Cancer | Cancer & Oncology | Hemangioendothelioma | Liver | Liver Transplant | Sarcomas | Transplant Surgery | Transplants | Urology & Nephrology